Pathways of apoptosis and the modulation of cell death in cancer

Hematology/Oncology Clinics of North America

Volumn 15, Issue 5, 2001, Pages 931-956

  Fisher, David E ^a,b  

^a Children's Hospital   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIBODY; PROTEIN BCL 2; PROTEIN P53; TUMOR NECROSIS FACTOR;

APOPTOSIS; B LYMPHOCYTE; CELL CYCLE; CELL DEATH; CELL SURVIVAL; ENZYME REGULATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; MODULATION; MOLECULAR EVOLUTION; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSACTIVATION;

EID: 0035663248     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70258-6     Document Type: Article

References (228)

1. The Bcl-2 protein family: Arbiters of cell survival
2. Human ICE/CED-3 protease nomenclature
3. Oncogenic activity of the c-Myc protein requires dimerization with Max
4. The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max
5. Inhibition of Bax channel-forming activity by Bcl- 2
6. Variant Max protein, derived by alternative splicing, associates with c-Myc in vivo and inhibits transactivation
7. Death receptors: Signaling and modulation
8. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis
9. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin 3
10. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: Clustering around JH on chromosome 14 and near a transcriptional unit on 18
11. Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p 53 gene mutations
12. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wildtype but not from oncogenic mutant p 53 protein
13. Interaction of c-Myc with the pRb-related protein p107 results in inhibition of c-Myc-mediated transactivation
14. The ornithine decarboxylase gene is a transcriptional target of c-Myc
15. Granzyme A loading induces rapid cytolysis and a novel form of DNA damage independently of caspase activation
16. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR 1
17. Sequence-specific DNA binding by the c-Myc protein
18. Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc
19. Perforin-dependent nuclear targeting of granzymes: A central role in the nuclear events of granule-exocytosis-mediated apoptosis?
20. Involvement of MACH, a novel MORT1/ FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
21. The protein bcl-2 alpha does not require membrane attachment, but two conserved domains to suppress apoptosis
22. Identification of apoptosis-associated proteins in a human Burkitt lymphoma cell line: Cleavage of heterogeneous nuclear ribonucleo-protein A 1 by caspase 3
23. An essential domain of the c-myc protein interacts with a nuclear factor that is also required for E1A-mediated transformation
24. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
25. Induction of the growth inhibitor IGF-binding protein 3 by p53
26. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes
27. Regulation of cell death protease caspase- 9 by phosphorylation
28. BCL-2 family: Regulators of cell death
29. BCL-2 family: Regulators of cell death
30. Conversion of Bcl-2 to a Bax-like death effector by caspases
31. Bax-independent inhibition of apoptosis by Bcl-XL
32. Role of CED-4 in the activation of CED-3
33. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
34. Interaction of CED-4 with CED-3 and CED-9: A molecular framework for cell death
35. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis
36. A conserved domain in Bak, distinct from BH1 and BH 2, mediates cell death and protein binding functions
37. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation
38. High-resolution structure of the oligomerization domain of p 53 by multidimensional NMR
39. The C. elegans protein EGL-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9
40. Regulation of lymphocyte survival by the bcl- 2 gene family
41. Enhanced cell survival and tumorigenesis
42. Specific cleavage of alpha-fodrin during Fas- and tumor necrosis factor-induced apoptosis is mediated by an interleukin-1beta-converting enzyme/Ced-3 protease distinct from the poly(ADP-ribose) polymerase protease
43. An intact zinc ring finger is required for tumor necrosis factor receptor-associated factor-mediated nuclear factor-kappaB activation but is dispensable for c-Jun N-terminal kinase signaling
44. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B
45. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
46. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt
47. Caenorhabditis elegans EGL-1 disrupts the interaction of CED-9 with CED-4 and promotes CED-3 activation
48. Prothymosin alpha binds histones in vitro and shows activity in nucleosome assembly assay
49. Essential role for caspase-8 in transcription-independent apoptosis triggered by p 53
50. Mechanisms of p53-mediated apoptosis
51. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition
52. Definition of a consensus binding site for p 53
53. Genetic control of programmed cell death in the nematode C. elegans
54. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
55. Induction of apoptosis in fibroblasts by c-myc protein
56. Bcl-2 associates with the ras-related protein R-ras p 23
57. Presence of a potent transcription activating sequence in the p 53 protein
58. Apoptosis in cancer therapy: Crossing the threshold
59. High affinity DNA-binding Myc analogs: Recognition by an alpha helix
60. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner
61. A transcriptionally active DNA-binding site for human p 53 protein complexes
62. Cdc25 cell-cycle phosphatase as a target of c-myc
63. Transcriptional activation by Myc is under negative control by the transcription factor AP-2
64. Epidermal growth factor protects epithelial cells against Fas-induced apoptosis: Requirement for Akt activation
65. Structure of the p 53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2
66. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo
67. Mitochondria and apoptosis
68. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: A role for TNF-R1 activation by endogenous membrane-anchored TNF
69. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis
70. Binding and suppression of the Myc transcriptional activation domain by p 107
71. Dissection of the genetic programs of p53-mediated G1 growth arrest and apoptosis: Blocking p53-induced apoptosis unmasks G 1 arrest
72. Identification of a large Myc-binding protein that contains RCC1-like repeats
73. Conformational shifts propagate from the oligomerization domain of p 53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants
74. MRIT, a novel death-effector domain-containing protein, interacts with caspases and BclXL and initiates cell death
75. Sin3 corepressor function in Myc-induced transcription and transformation
76. c-Myc-induced apoptosis in fibroblasts in inhibited by specific cytokines
77. Oncogenes and cell death
78. Clinical implications of the p53 tumor-suppressor gene
79. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2
80. A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain
81. Interleukin-6- and leukemia inhibitory factor-induced terminal differentiation of myeloid leukemia cells is blocked at an intermediate stage by constitutive c-myc
82. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor- 1 signaling complex
83. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
84. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation
85. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase- 9 activation
86. Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase- 9 activation and apoptosis
87. Novel p53-inducible gene, PAG 608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis
88. Two cellular proteins that bind to wild-type but not mutant p 53
89. Synergistic anti-apoptotic activity between Bcl- 2 and SMN implicated in spinal muscular atrophy
90. Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis
91. Crystal structure of the tetramerization domain of the p 53 tumor suppressor at 1.7 angstroms
92. A transactivation-deficient mouse model provides insights into Trp 53 regulation and function
93. Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death
94. Bcl-2-family proteins: The role of the BH 3 domain in apoptosis
95. Apoptosis: A basic biological phenomenon with wideranging implications in tissue kinetics
96. Bcl- 2 and Bax function independently to regulate cell death
97. Investigation of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes
98. The proto-oncogene Bcl-2 and its role in regulating apoptosis
99. The cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast two-hybrid system
100. Regulation of Bcl-xl channel activity by calcium
101. The leucine zipper: A hypothetical structure common to a new class of DNA binding proteins
102. Solution structure of the tetrameric minimum transforming domain of p 53
103. The tumor suppressor genes
104. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
105. c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II
106. Cytochrome c and dATP-dependent formation of Apaf-1/caspase- 9 complex initiates an apoptotic protease cascade
107. DFF a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis
108. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
109. Alternative forms of Max as enhancers or suppressors of Myc-ras contransformation
110. Fas-induced caspase denitrosylation
111. Release of cytochrome c and decrease of cytochrome c oxidase in Bax-expressing yeast cells, and prevention of these effects by coexpression of Bcl-xL
112. Myc represses the growth arrest gene gadd 45
113. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis
114. Actin cleavage by CPP-32/apopain during the development of apoptosis
115. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl- 2 homologue Bak
116. p53 and cancer therapy: A double-edged sword
117. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E 2F oncoproteins
118. Bcl-x(L) forms an ion channel in synthetic lipid membranes
119. Tumor suppressor p53 is a regulator of bcl- 2 and bax gene expression in vitro and in vivo
120. Tumor suppressor p 53 is a direct transcriptional activator of the human bax gene
121. MM-1, a novel c-Myc-associating protein that represses transcriptional activity of c-Myc
122. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death
123. Myc family oncoproteins function through a common pathway to transform normal cells in culture: Cross-interference by Max and trans-acting dominant mutants
124. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wildtype p 53
125. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins
126. An induced proximity model for caspase- 8 activation
127. Apoptosis by death factor
128. Non-erythroid alpha-spectrin breakdown by calpain and interleukin I beta-converting-enzyme-like protease(s) in apoptotic cells: Contributory roles of both protease families in neuronal apoptosis
129. The p53-binding protein 53BP2 also interacts with Bcl2 and impedes cell cycle progression at G2/M
130. p28 Bap31, a Bcl-2/Bcl-XL- and procaspase-8-associated protein in the endoplasmic reticulum
131. Role of membrane anchor domain of Bcl-2 in suppression of apoptosis caused by E1B-defective adenovirus
132. Caspases: Killer proteases
133. Caspases: The proteases of the apoptotic pathway
134. Apoptosis and expression of cytotoxic T lymphocyte effector molecules in renal allografts
135. Checkpoints of dueling dimers foil death wishes
136. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death
137. Wild-type human p53 and a temperaturesensitive mutant induce Fas/APO-1 expression
138. c-Myc and apoptosis
139. Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex
140. Tumor necrosis factor induces phosphorylation and translocation of BAD through a phosphatidylinositide-3-OH kinase-dependent pathway
141. The DNA-binding domain of p 53 contains the four conserved regions and the major mutation hot spots
142. An alternative pathway for gene regulation by Myc
143. A model for p53-induced apoptosis
144. Mechanisms of apoptosis by c-Myc
145. Differential patterns of DNA binding by myc and max proteins
146. Bcl- 2 and the regulation of programmed cell death
147. Bcl-2 family proteins
148. The p53 targets mdm2 and Fas are not required as mediators of apoptosis in vivo
149. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c
150. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins
151. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40
152. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor
153. The three-dimensional structure of apopain/CPP 32, a key mediator of apoptosis
154. Direct role for Myc in transcription initiation mediated by interactions with TFII-I
155. Cloning of an inr- and E-box-binding protein, TFIII, that interacts physically and functionally with USF 1
156. An alternative pathway for transcription initiation involving TFII-I
157. p53 and response to chemotherapy and radiotherapy
158. Analysis of a protein-binding domain of p 53
159. BIN1 is a novel MYC-interacting protein with features of a tumour suppressor
160. New Myc-interacting proteins: A second Myc network emerges
161. Tralp is a component of the yeast Ada.Spt transcriptional regulatory complexes
162. Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation
163. Caspases: Intracellular signaling by proteolysis
164. Structure of Bcl-xL-Bak peptide complex: Recognition between regulators of apoptosis
165. The HPV-16 E6 and E6-AP complex functions as a ubiquitinprotein ligase in the ubiquitination of p 53
166. Channel formation by antiapoptotic protein Bcl-2
167. Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2
168. The human tumor necrosis factor (TNF) receptorassociated factor 1 gene (TRAF1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-kappaB and c-Jun N-terminal kinase
169. Immediate early up-regulation of bax expression by p53 but not TGF beta 1: A paradigm for distinct apoptotic pathways
170. The novel primary response gene MyD118 and the proto-oncogenes myb, myc, and bcl-2 modulate transforming growth factor beta 1-induced apoptosis of myeloid leukemia cells
171. TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b
172. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2
173. Endothelin-1 is a potent survival factor for c-Myc-dependent apoptosis
174. A unique glucose-dependent apoptotic pathway induced by c-Myc
175. Bcl- 2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC
176. Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc
177. Bak can accelerate chemotherapy-induced cell death independently of its heterodimerization with Bcl-XL and Bcl- 2
178. Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL
179. Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner
180. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
181. Interaction between the C. elegans cell-death regulators CED-9 and CED- 4
182. Autoactivation of procaspase-9 by Apaf-l-mediated oligomerization
183. Repression of p15INK4b expression by Myc through association with Miz-1
184. Definition of regions in human c-myc that are involved in transformation and nuclear localization
185. The role of the bcl-2/ced- 9 gene family in cancer and general implications of defects in cell death control for tumourigenesis and resistance to chemotherapy
186. Selective sensitization to tumor necrosis factor-alpha-induced apoptosis by blockade of NF-kappaB in primary glomerular mesangial cells
187. Bcl- 2 inhibits the mitochondrial release of an apoptogenic protease
188. The central executioner of apoptosis: Multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis
189. AMY-1, a novel C-MYC binding protein that stimulates transcription activity of C-MYC
190. Cleavage of lamin A by Mch2 alpha but not CPP32: Multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis
191. Cloning and functional analysis of BAG-1: A novel Bcl-2-binding protein with anti-cell death activity
192. Substrate specificities of caspase family proteases
193. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells
194. Modulation of cell death in yeast by the Bcl- 2 family of proteins
195. The many roles of c-Myc in apoptosis
196. A novel heterodimeric cysteine protease is required for interleukin- 1 beta processing in monocytes
197. Caspases: Enemies within
198. A combinatorial approach defines specificities of members of the caspase family and granzyme B: Functional relationships established for key mediators of apoptosis
199. RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis
200. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation
201. p53: A transdominant regulator of transcription whose function is ablated by mutations occurring in human cancer
202. A potential mechanism of "cross-talk" between the p55 tumor necrosis factor receptor and Fas/APO1: Proteins binding to the death domains of the two receptors also bind to each other
203. Determination of sequences responsible for the differential regulation of Myc function by delta Max and Max
204. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
205. Prevention of programmed cell death in Caenorhabditis elegans by human bcl- 2
206. Identification of DIABLO a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins
207. c-Myc induces the expression and activity of ornithine decarboxylase
208. Identification of a novel p 53 functional domain that is necessary for efficient growth suppression
209. Crystal structure of the cysteine protease interleukin-I beta-converting enzyme: A (p20/p10) 2 homodimer
210. Apoptosis regulation by interaction of Bcl-2 protein and Raf- 1 kinase
211. Bcl-2 targets the protein kinase Raf- 1 to mitochondria
212. Mutagenesis of the BH 3 domain of BAX identifies residues critical for dimerization and killing
213. BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells
214. p53 domains: Identification and characterization of two autonomous DNA-binding regions
215. Structure and mechanism of interleukin- 1 beta converting enzyme
216. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene
217. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases
218. Bax inhibitor- 1, a mammalian apoptosis suppressor identified by functional screening in yeast
219. Caenorhabditis elegans CED-9 protein is a bifunctional cell-death inhibitor
220. Molecular thanatopsis: A discourse on the BCL 2 family and cell death
221. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax
222. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis
223. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme
224. Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteins
225. Heterodimerization-independent functions of cell death regulatory proteins Bax and Bcl-2 in yeast and mammalian cells
226. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X
227. A role for c-myc in chemically induced renal-cell death
228. Apaf-1 a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase- 3